Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 206-212

  Han, Chunjie ^a   Liu, Juntian ^a   Liu, Xiaofang ^a   Li, Ming ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiotensin II; Atherosclerosis; C reactive protein; Human aortic endothelial cell; Inflammation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; C REACTIVE PROTEIN; DIPHENYLIODONIUM SALT; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 6 ANTIBODY; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; THENOYLTRIFLUOROACETONE;

AORTA; ARTICLE; ATHEROSCLEROSIS; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; BLOTTING, WESTERN; C-REACTIVE PROTEIN; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 77956228544     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.020     Document Type: Article

References (30)

1. Bermudez E.A., Rifai N., Buring J., et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002, 22:1668-1673.
2. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
3. Kibayashi E., Urakaze M., Kobashi C., et al. Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells. Clin Sci 2005, 108:515-521.
4. Li L., Roumeliotis N., Sawamura T., et al. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res 2004, 95:877-883.
5. Venugopal S.K., Devaraj S., Yuhanna I., et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106:1439-1441.
6. Venugopal S.K., Devaraj S., Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation 2003, 108:1676-1678.
7. Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930-1932.
8. Singh P., Hoffmann M., Wolk R., et al. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2007, 27:e302-e307.
9. Yasojima K., Schwab C., McGeer E.G., et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001, 158:1039-1051.
10. Venugopal S.K., Devaraj S., Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol 2005, 166:1265-1271.
11. Schmidt-Ott K.M., Kagiyama S., Phillips M.I. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000, 93:65-77.
12. Ko Y.J., Lee J.S., Park B.C., et al. Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells. Vasc Pharmacol 2007, 47:189-196.
13. Kunieda Y., Nakagawa K., Nishimura H., et al. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thromb Res 2003, 110:227-234.
14. Liu H.Q., Wei X.B., Sun R., et al. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life Sci 2006, 78:1293-1298.
15. Peng N., Liu J.T., Gao D.F., et al. Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 2007, 193:292-298.
16. Hsieh H.L., Wu C.B., Sun C.C., et al. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathway in rat vascular smooth muscle cells. J Cell Physiol 2006, 207:757-766.
17. Parinandi N.L., Kleinberg M.A., Usatyuk P.V., et al. Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 2003, 284:L26-38.
18. Yasojima K., Schwab C., McGeer E.G., et al. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 2000, 887:80-89.
19. Jabs W.J., Logering B.A., Gerke P., et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 2003, 33:152-161.
20. Gould J.M., Weiser J.N. Expression of C-reactive protein in the human respiratory tract. Infect Immun 2001, 69:1747-1754.
21. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
22. Ayabe N., Babaev R.V., Tang Y.W., et al. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis 2006, 184:312-321.
23. Cunha D.V., Tham M.D., Martin-Mcnulty B., et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005, 178:9-17.
24. Devaraj S., Du Clos T.W., Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 2005, 25:1359-1363.
25. Li D., Saldeen T., Romeo F., et al. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 2000, 102:1970-1976.
26. Hsu Y.H., Chen J.J., Chang N.C., et al. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J Vasc Res 2004, 41:64-74.
27. Miyazawa N., Abe M., Souma T., et al. Methylglyoxal augments intracellular oxidative stress in human aortic endothelial cells. Free Radic Res 2010, 44:101-107.
28. Chan S.H., Hsu K.S., Huang C.C., et al. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005, 97:772-780.
29. Guo R.W., Yang L.X., Li M.Q., et al. Angiotensin II induces NF-kappa B activation in HUVEC via the p38MAPK pathway. Peptides 2006, 27:3269-3275.
30. Pan Q., Yang X.H., Cheng Y.X. Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling. Braz J Med Biol Res 2009, 42:531-536.